| • |
our audited consolidated financial statements as of and for the fiscal year ended December 31, 2020 and the related notes;
|
| • |
audited financial statements of Trianni as of and for the fiscal year ended December 31, 2019 and the related notes; and
|
| • |
unaudited condensed financial statements of Trianni as of and for the nine months ended September 30, 2020 and the related notes.
|
|
|
Year Ended
December 31, 2020 AbCellera |
Nine Months
Ended September 30, 2020 Trianni (Note 4) |
October 1,
2020 – November 2, 2020 Trianni |
Transaction
Accounting Adjustments |
Notes
|
Combined
|
||||||||||||||||||
|
Revenue:
|
||||||||||||||||||||||||
|
Research fees
|
$
|
19,848
|
—
|
—
|
—
|
$
|
19,848
|
|||||||||||||||||
|
Milestone payments
|
15,000
|
—
|
—
|
15,000
|
||||||||||||||||||||
|
License
|
—
|
5,946
|
309
|
6,255
|
||||||||||||||||||||
|
Royalty revenue
|
198,307
|
—
|
—
|
—
|
198,307
|
|||||||||||||||||||
|
Total revenue
|
$
|
233,155
|
$
|
5,946
|
309
|
—
|
$
|
239,410
|
||||||||||||||||
|
Operating expenses:
|
||||||||||||||||||||||||
|
Royalty fees
|
27,143
|
—
|
—
|
—
|
27,143
|
|||||||||||||||||||
|
Research and development (1)
|
29,393
|
2,374
|
749
|
—
|
32,516
|
|||||||||||||||||||
|
Sales and marketing (1)
|
3,842
|
—
|
—
|
—
|
3,842
|
|||||||||||||||||||
|
General and administrative(1)
|
11,910
|
1,322
|
41
|
—
|
13,273
|
|||||||||||||||||||
|
Depreciation and amortization
|
4,836
|
—
|
—
|
5,723
|
[5A
|
]
|
10,559
|
|||||||||||||||||
|
Total operating expenses
|
$
|
77,124
|
$
|
3,696
|
790
|
$
|
5,723
|
$
|
87,333
|
|||||||||||||||
|
Income (loss) from operations
|
156,031
|
2,250
|
(481
|
)
|
(5,723
|
)
|
152,077
|
|||||||||||||||||
|
Other (income) expense:
|
||||||||||||||||||||||||
|
Interest income
|
(293
|
)
|
(150
|
)
|
—
|
—
|
(443
|
)
|
||||||||||||||||
|
Interest expense and other (income) expense
|
6,511
|
(1
|
)
|
—
|
2,928
|
[5B
|
]
|
9,438
|
||||||||||||||||
|
Foreign exchange (gain) loss
|
300
|
—
|
—
|
—
|
300
|
|||||||||||||||||||
|
Grants and incentives
|
(8,320
|
)
|
—
|
—
|
—
|
(8,320
|
)
|
|||||||||||||||||
|
Total other (income) expense
|
(1,802
|
)
|
(151
|
)
|
—
|
2,928
|
975
|
|||||||||||||||||
|
Earnings before income taxes
|
157,833
|
2,401
|
(481
|
)
|
(8,651
|
)
|
151,102
|
|||||||||||||||||
|
Income tax provision (recovery)
|
38,915
|
118
|
(125
|
)
|
(2,249
|
)
|
[5C
|
]
|
36,659
|
|||||||||||||||
|
Net earnings (loss) for the period
|
$
|
118,918
|
$
|
2,283
|
(356
|
)
|
$
|
(6,402
|
)
|
$
|
114,443
|
|||||||||||||
|
Net earnings per share, basic (Note 6)
|
$
|
0.53
|
$
|
0.52
|
||||||||||||||||||||
|
Net earnings per share, diluted (Note 6)
|
$
|
0.45
|
$
|
0.43
|
||||||||||||||||||||
| • |
the impact of any potential revenues, benefits or synergies that may be achievable in connection with the merger or related costs that may be required to achieve such
revenues, benefits or synergies;
|
| • |
changes in cost structure or any restructuring activities as such changes, if any, have yet to be determined; and
|
| • |
ASU No. 2016-02, Leases (Topic 842) , which is referred to
as ASC 842—Trianni has not yet adopted ASC 842, and we adopted it with an effective date of January 1, 2019. For purposes of the unaudited condensed combined pro forma statements of operations for the year ended December 31, 2020, Trianni
only had one operating lease as classified under ASC 842. Any resulting change would be immaterial and thus, for the purposes of the pro forma financial information, Trianni has not adjusted AbCellera’s adoption of ASC 842 to January 1,
2020.
|
| • |
ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326):
Measurement of Credit Losses on Financial Instruments , which is referred to as ASC 326. Trianni’s historical financial statements used to derive the pro forma financial information do not reflect the adoption of ASC 326. For the
purposes of the pro forma financial information, we have not adjusted Trianni’s adoption of ASC 326 to January 1, 2020 as the estimated impact on the pro forma financial information would be immaterial.
|
|
(in thousands, except for per share amounts)
|
Year Ended
December 31, 2020 |
|||
|
Pro forma net earnings
|
$
|
114,443
|
||
|
Less pro forma earnings allocated to Preferred Shareholders
|
(32,044
|
)
|
||
|
Pro forma net earnings attributable to common shareholders
|
82,399
|
|||
|
Pro forma basic weighted-average shares outstanding
|
159,195,023
|
|||
|
Pro forma basic earnings per share
|
$
|
0.52
|
||
|
(in thousands, except for per share amounts)
|
Year Ended
December 31, 2020 |
|||
|
Pro forma net earnings attributable to common shareholders
|
$
|
114,443
|
||
|
Pro forma diluted weighted-average shares outstanding
|
263,129,765
|
|||
|
Pro forma diluted earnings per share
|
$
|
0.43
|
||